|
1
|
Wu HH, Lin W and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanat O and O'Neil BH: Metastatic gastric
cancer treatment: A little slow but worthy progress. Med Oncol.
30:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu YD, Liu YQ, Qian YY, Zhang H, Li GQ
and Yang L: Extracts of Celastrus orbiculatus exhibit
anti-proliferative and anti-invasive effects on human
gastricadenocarcinoma cells. Chin J Integr Med. Nov 10–2014.(Epub
ahead of print). View Article : Google Scholar
|
|
5
|
Wang S, Zhong Z, Wan J, Tan W, Wu G, Chen
M and Wang Y: Oridonin induces apoptosis, inhibits migration and
invasion on highly-metastatic human breast cancer cells. Am J Chin
Med. 41:177–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tarakji B, Ashok N, Sheirawan MK, Altamimi
MA, Alenzi F, Azzeghaiby SN, Baroudi K and Nassani MZ: Maspin as a
tumour suppressor in salivary gland tumour. J Clin Diagn Res.
8:ZE05–ZE07. 2014.PubMed/NCBI
|
|
7
|
Bodenstine TM, Seftor RE, Seftor EA,
Khalkhali-Ellis Z, Samii NA, Monarrez JC, Chandler GS, Pemberton PA
and Hendrix MJ: Internalization by multiple endocytic pathways and
lysosomal processing impact maspin-based therapeutics. Mol Cancer
Res. 12:1480–1491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lovato A, Lionello M, Staffieri A,
Blandamura S, Tealdo G, Giacomelli L, Staffieri C and Marioni G: A
higher angiogenin expression is associated with a nonnuclear maspin
location in laryngeal carcinoma. Clin Exp Otorhinolaryngol.
8:268–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bagheri M, Eghtedari M, Bagheri M,
Geramizadeh B and Talebnejad M: Expression of Maspin and Ezrin
proteins in periocular basal cell carcinoma. Dermatol Res Pract.
2014:5965642014.PubMed/NCBI
|
|
10
|
Dzinic SH, Chen K, Thakur A, Kaplun A,
Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, et al:
Maspin expression in prostate tumor elicits host anti-tumor
immunity. Oncotarget. 5:11225–11236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lonardo F, Guan H, Dzinic S and Sheng S:
Maspin expression patterns differ in the invasive versus lepidic
growth pattern of pulmonary adenocarcinoma. Histopathology.
65:757–763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang WM, Liu YQ and Dai XJ: Apoptosis of
Hela cell induced by Celastrus orbiculatus Thunb extract and
primary mechanisms. Chin-German J Clin Oncol. 10:666–668. 2011.
View Article : Google Scholar
|
|
13
|
Qian YY, Zhang H, Hou Y, Yuan L, Li GQ,
Guo SY, Hisamits T and Liu YQ: Celastrus orbiculatus extract
inhibits tumor angiogenesis by targeting vascular endothelial
growth factor signaling pathway and shows potent antitumor activity
in hepatocarcinomas in vitro and in vivo. Chin J Integr Med.
18:752–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma H, Qian YY, Zhang H, Xue JI, Yaodong
ZHU, Pingfang CUI and Yanqing LIU: Celastrus orbiculatus extract
could inhibit human colorectal carcinoma HT-29 cells metastasis via
suppression of the mTOR signaling pathway. Life Sci J.
10:1704–1710. 2013.
|
|
15
|
Zhang H, Qian Y, Liu Y, Li G, Cui P, Zhu
Y, Ma H, Ji X, Guo S and Tadashi H: Celastrus orbiculatus extract
induces mitochondrial-mediated apoptosis in human hepatocellular
carcinoma cells. J Tradit Chin Med. 32:621–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong M, Wang N, Tan HY, Tsao SW and Feng
Y: MicroRNAs and Chinese medicinal herbs: New possibilities in
cancer therapy. Cancers (Basel). 7:1643–1657. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su CX, Wang LQ, Grant SJ and Liu JP:
Chinese herbal medicine for cancer-related fatigue: A systematic
review of randomized clinical trials. Complement Ther Med.
22:567–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CM, Lin LZ and Zhang EX: Standardized
treatment of Chinese medicine decoction for cancer pain patients
with opioid-induced constipation: A multi-center prospective
randomized controlled study. Chin J Integr Med. 20:496–502. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo FR, Ding J, Chen HX, Liu H, Fung MC,
Koehler M, Armand JP, Jiang L, Xu X, Zhang G, et al: Breakthrough
cancer medicine and its impact on novel drug development in China:
Report of the US Chinese anti-cancer association (USCACA) and
Chinese society of clinical oncology (Csco) joint session at the
17th CSCO annual meeting. Chin J Cancer. 33:620–624.
2014.PubMed/NCBI
|
|
21
|
Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen
J, Guo S and Hisamitsu T: Antimetastatic effects of Celastrus
orbiculatus on humangastric adenocarcinoma by inhibiting
epithelial-mesenchymal transition and NF-κB/snail signaling
pathway. Integr Cancer Ther. 14:271–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen
J, Guo S and Hisamitsu T: Research on the efficacy of Celastrus
Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal
transition by inhibiting HSP27 and TNF-α-induced NF-κB/Snail
signaling pathway in human gastric adenocarcinoma. BMC Complement
Altern Med. 14:4332014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang M, Zhang X, Xiong X, Yang Z, Sun Y,
Yang Z, Hoffman RM and Liu Y: Efficacy of the Chinese traditional
medicinal herb Celastrus orbiculatus Thunb on human hepatocellular
carcinoma in an orthothopic fluorescent nude mouse model.
Anticancer Res. 32:1213–1220. 2012.PubMed/NCBI
|
|
24
|
Jeon H: Anti-metastatic effects of
celastrus orbiculatus extract in B16F10 melanoma cells. Nat Prod
Sci. 17:135–141. 2011.
|
|
25
|
Jin X and Shi YI: Isobavachalcone induces
the apoptosis of gastric cancer cells via inhibition of the Akt and
Erk pathways. Exp Ther Med. 11:403–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nguyen KC, Willmore WG and Tayabali AF:
Cadmium tellunde quantum dots cause oxidative stress leading to
extnnsic and intrinsic apoptosis in hepatocellular carcinoma HepG2
cells. Toxicology. 306:114–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu R, Duan L, Ye L, Wang H, Yang X, Zhang
Y, Chen X, Zhang Y, Weng Y, Luo J, et al: S100A9 promotes the
proliferation and invasion of HepG2 hepatocellular carcinoma cells
via the activation of the MAPK signaling pathway. Int J Oncol.
42:1001–1010. 2013. View Article : Google Scholar : PubMed/NCBI
|
